Denemek ALTIN - Özgür
13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors
Bio Spectrum
|September 2024
The 13th edition of Bengaluru INDIA NANO 2024, organised by the Department of Science & Technology, Government of Karnataka, Karnataka Science & Technology Promotion Society (KSTePS), and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) concluded on August 3 with participation of 1018 delegates, 11 countries including Korea, Morocco, USA, UK, France, Canada, Germany, Netherlands, Russia, Japan, and Poland, 49 exhibitors comprising 21 startups and 28 industry and institutes, and 200 posters. The exhibition had a footfall of 3,000+ visitors.
-
The conference featured 81 distinguished speakers across 41 sessions, exploring a broad range of topics from cutting-edge research to practical industry applications in nanotechnology. Over 200 young attendees participated in the pre-conference tutorials.
During the two days sessions on "Nano in Healthcare", Prof. Dhirendra Katti, Director, IIT Goa spoke on 'Development of a Vaccines/Nano vaccines for Multi-drug Resistant Diarrhoea'; Dr Jiban Jyoti Panda, Associate Professor, Institute of Nano Science and Technology, Mohali spoke on 'Brain targeting Small Molecular Nanomedicines', Prof. Biman B. Mandal, Professor, IIT Guwahati shared his views on 'Nano-Composite Silk Hydrogel for Spatiotemporal, Targeted and On-Demand Controlled Release of Chemotherapeutics: An In Vivo Approach toward Suppressing Solid Tumour Growth', This session was chaired by Prof. Swaminathan, Professor & Director, SASTRA University.
Dr Praveen Kumar Vemula, Faculty, DBT INSTEM chaired a second session on Nano in Healthcare in which Prof. Neetu Singh, Professor & Head, Center for Biomedical Engineering, Indian Institute of Technology Delhi shared her views on the topic '3D Liver Platforms For In-Situ Disease Staging' and in his presentation Prof. Bikramjit Basu, Professor, IISc Bangalore touched upon 'Size-tailored Gold Nanoparticles: Novel electroactuators to guide stem cell differentiation and as bacteriotoxic agents' and Prof. K. Uma Maheswari, Professor, Sastra University spoke on Smart Non-intervention for Therapy.
Dr Taslimarif Syed, CEO and Director, C- CAMP, moderated a panel discussion on 'Healthcare & Medical Electronics' with Dr Aditya Kulkarni,
Bu hikaye Bio Spectrum dergisinin September 2024 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Bio Spectrum'den DAHA FAZLA HİKAYE
Bio Spectrum
“The N-FIS market is no longer emerging; it's aligning with where healthcare is headed”
Once viewed as a niche innovation, Needle-Free Injection System (N-FIS) are now evolving into a multi-therapy drug delivery solution, with growing applications across paediatrics, vaccination, in vitro fertilisation (IVF), pain management, and the rapidly expanding GLP-1 therapy segment.
5 mins
July 2026
Bio Spectrum
Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing
Imaging Endpoints, a Hyderabad-based oncologyfocused imaging contract research organisation (CRO), has appointed Srikanth Ayyappan as Associate Vice President (AVP), Global Marketing.
1 min
July 2026
Bio Spectrum
Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery
US-based Cytiva, a Danaher company, is introducing the next generation of its Biacore 8 series SPR systems, enabling scientists to generate reliable interaction data faster, as drug discovery grows more complex.
1 min
July 2026
Bio Spectrum
Decentralization and Fragmentation in Bioprocessing Industry
The global bioprocessing industry is undergoing a fundamental transformation.
2 mins
July 2026
Bio Spectrum
Vijay TS steps in as CPO at Redcliffe Labs
Noida-based Redcliffe Labs has announced the appointment of Vijay T. S. as Chief People Officer (CPO), as the company continues to strengthen its organisational foundation to support its next phase of growth and expansion across India.
1 min
July 2026
Bio Spectrum
Dr Sanjay Chaturvedi takes charge as CEO at Matrix Pharmacorn
Telangana-based Matrix Pharmacorp has announced the appointment of Dr Sanjay Chaturvedi as Chief Executive Officer (CEO).
1 min
July 2026
Bio Spectrum
How Mergers and Acquisitions Spell Success for Pharma Companies
The recent acquisition of Organon by Sun Pharmaceutical Industries marks one of the largest pharmaceutical deals involving an Indian company. The all-cash transaction, valued at approximately $11.75 billion, highlights the growing global ambitions of Indian pharmaceutical firms. The latest mergers and acquisitions (M&A) have emerged as a strategic tool for pharmaceutical companies to strengthen market presence, what the future holds and the associated risks. However, challenges remain. Let us delve deep into what goes into these huge M&A transactions and what can be the likely challenges.
6 mins
July 2026
Bio Spectrum
Align Technology to open multi-million dollar manufacturing facility in Hyderabad
Align Technology, Inc., a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners and services, and exocad CAD/ CAM software for digital orthodontics and restorative dentistry, has announced plans to open a new manufacturing facility in Hyderabad, in 2027, create more than 300 direct jobs, and spend approximately $200 million in both capital and operational expense over the next several years.
1 min
July 2026
Bio Spectrum
Pharma Fermentation: India's Next Biomanufacturing Opportunity
Driven by increasing demand for biologics, antibiotics, enzymes, biosimilars, and services offered by Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Development and Manufacturing Organisations (CRDMOs), the Indian pharmaceutical fermentation market is witnessing strong growth. The industry is gradually shifting from the production of traditional generic medicines toward higher-value, fermentation-based products, reflecting the growing importance of complex biologics and advanced therapeutics. According to IMARC Group, the India fermentation chemicals market reached $3.2 billion in 2025 and is projected to grow to $5.5 billion by 2034, exhibiting a CAGR of 5.79 per cent during 2026-2034. However, growth alone will not guarantee leadership. India’s ability to build a robust domestic fermentation ecosystem, reduce import dependence, and scale advanced biomanufacturing capabilities will determine whether it can emerge as a global fermentation hub. Let's explore further.
7 mins
July 2026
Bio Spectrum
GVRP & StepsBio unveil new formulations R&D centre in Bengaluru
GVRP (GV Research Platform), a Hyderabadbased research organisation, has announced the inauguration of the GVRP Steps Bio Research Centre (GSRC), a strategic collaboration with Bengalurubased startup Steps Biosciences that marks a significant milestone in India's pharmaceutical R&D landscape.
1 min
July 2026
Listen
Translate
Change font size
